Drug Oncology

Kisqali

Payments companies reported to CMS as associated with Kisqali. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$5.4Massociated payments (2023-2025)
11,343clinicians with associated payments
3companies reporting

By year

2023 $1.0M
2024 $2.0M
2025 $2.4M

Payments reported as associated with Kisqali, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Hematology & Oncology $1.5M
Medical Oncology $735K
Nurse Practitioner $553K
Family $461K
Pediatrics (Nurse Practitioner) $394K
Adult Health (Nurse Practitioner) $203K

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Kisqali

These are the largest totals companies reported as associated with Kisqali. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Wendy Hein Kansas City, KS Pediatrics (Nurse Practitioner) $393,516.31
Adissa Perez Winter Park, FL Nurse Practitioner $342,977.75
Elizabeth Weaver Columbus, OH Gerontology (Clinical Nurse Specialist) $175,394.69
Andrea Ventola Florham Park, NJ Obstetrics & Gynecology (Nurse Practitioner) $144,895.79
John Osborne Grapevine, TX Cardiovascular Disease $141,160.00
Kathryn Simone Blue Springs, MO Women'S Health (Nurse Practitioner) $136,178.92
Leah Ehle Manchester, CT Adult Health (Nurse Practitioner) $111,461.24
Kara Trlica Cranbury, NJ Family $83,964.37
Michael Siegal New York, NY $36,870.00
Grant Simons Englewood, NJ Clinical Cardiac Electrophysiology $35,155.00

Prescribed Kisqali?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.